Opioid use following otolaryngology surgical procedures has received increased interest, with many studies recommending shorter-term prescriptions for opioids to avoid dependence on the drugs. In response to a continuing opioid crisis in the United States, the FDA announced on July 23 that it will require that labeling for opioid pain medicine and medicine to treat […]
Articles tagged with "FDA"
Updated April 10, 2020. The U.S. Food and Drug Administration announced on April 1 that it is immediately pulling all prescription and over-the-counter ranitidine (brand name Zantac) drugs from the market because of an impurity issue. Although most recalls are the result of contamination that occurs at some point during the drug production cycle, this […]
A new study concludes that cochlear implantation is commonly performed for indications beyond those included in FDA-approved labeling
The FDA takes steps to better support consumer access to hearing aids.